200 related articles for article (PubMed ID: 18465143)
21. Synergism therapeutic and immunoregulatory effects of Albendazole + rAd-mIL-28B against Echinococcosis in experiment-infected mice with protoscoleces.
Zhang Y; Wang J; Yang Q; Li Z; Xu X; Chen C; Hou Z; He Q; Sheng L; Ma X; Luo Y
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009927. PubMed ID: 34818327
[TBL] [Abstract][Full Text] [Related]
22. In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice.
Pérez-Serrano J; Denegri G; Casado N; Rodríguez-Caabeiro F
Int J Parasitol; 1997 Nov; 27(11):1341-5. PubMed ID: 9421721
[TBL] [Abstract][Full Text] [Related]
23. The effect of albendazole sulfoxide on the expression of miR-61 and let-7 in different in vitro developmental stages of Echinococcus granulosus.
Mortezaei S; Afgar A; Mohammadi MA; Mousavi SM; Sadeghi B; Harandi MF
Acta Trop; 2019 Jul; 195():97-102. PubMed ID: 31051116
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice.
Vural G; Yardimci M; Kocak M; Yasar TÖ; Kurt A; Harem IS; Carradori S; Sciamanna I; Siles-Lucas M; Fabiani M; Hemphill A; Lundström-Stadelmann B; Cirilli R; Casulli A
Parasitology; 2020 Nov; 147(13):1425-1432. PubMed ID: 32729453
[TBL] [Abstract][Full Text] [Related]
25. Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: Pharmacokinetic and efficacy assessment in mice.
Laura C; Celina E; Sergio SB; Guillermo D; Carlos L; Luis A
Acta Trop; 2015 Aug; 148():89-96. PubMed ID: 25917712
[TBL] [Abstract][Full Text] [Related]
26. Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.
Mingjie W; Shuhua X; Junjie C; Bin L; Cheng F; Weixia S; Hotez P
Acta Trop; 2002 Aug; 83(2):177-81. PubMed ID: 12088859
[TBL] [Abstract][Full Text] [Related]
27. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
García JJ; Bolás F; Torrado JJ
Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162
[TBL] [Abstract][Full Text] [Related]
28. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep.
Alvarez LI; Imperiale FA; Sánchez SF; Murno GA; Lanusse CE
Vet Parasitol; 2000 Dec; 94(1-2):75-89. PubMed ID: 11078946
[TBL] [Abstract][Full Text] [Related]
29. Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis.
Pensel PE; Castro S; Allemandi D; Bruni SS; Palma SD; Elissondo MC
Vet Parasitol; 2014 Jun; 203(1-2):80-6. PubMed ID: 24572043
[TBL] [Abstract][Full Text] [Related]
30. Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice.
Ceballos L; Elissondo M; Bruni SS; Denegri G; Alvarez L; Lanusse C
Parasitol Int; 2009 Dec; 58(4):354-8. PubMed ID: 19628054
[TBL] [Abstract][Full Text] [Related]
31. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
Ahmadnia S; Moazeni M; Mohammadi-Samani S; Oryan A
Exp Parasitol; 2013 Oct; 135(2):314-9. PubMed ID: 23912040
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
[TBL] [Abstract][Full Text] [Related]
33. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
34. Chemoprophylactic and therapeutic efficacy of thymol in murine cystic echinococcosis.
Maggiore M; Pensel PE; Denegri G; Elissondo MC
Parasitol Int; 2015 Oct; 64(5):435-40. PubMed ID: 26096310
[TBL] [Abstract][Full Text] [Related]
35. A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach.
Labsi M; Soufli I; Khelifi L; Amir ZC; Touil-Boukoffa C
Acta Trop; 2019 Sep; 197():105050. PubMed ID: 31170379
[TBL] [Abstract][Full Text] [Related]
36. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
Lopez-Garcia ML; Torrado-Duran S; Torrado-Duran J; Martínez-Fernández AR; Bolás-Fernández F
Int J Parasitol; 1997 Jul; 27(7):781-5. PubMed ID: 9279580
[TBL] [Abstract][Full Text] [Related]
37. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
Stettler M; Rossignol JF; Fink R; Walker M; Gottstein B; Merli M; Theurillat R; Thormann W; Dricot E; Segers R; Hemphill A
Int J Parasitol; 2004 Apr; 34(5):615-24. PubMed ID: 15064126
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis.
Wang W; Li J; Yao J; Wang T; Li S; Zheng X; Duan L; Zhang W
J Antimicrob Chemother; 2017 Nov; 72(11):3122-3130. PubMed ID: 28981899
[TBL] [Abstract][Full Text] [Related]
39. Disposition kinetics of albendazole and metabolites in laying hens.
Bistoletti M; Alvarez L; Lanusse C; Moreno L
J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
[TBL] [Abstract][Full Text] [Related]
40. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
Alvarez LI; Sánchez SF; Lanusse CE
J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
